FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Achives
 
Powered by Google
 

PDUFA Federal Register Documents

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2009 [Text] [PDF] (Posted 7/31/2008)

  • Notice of Availability: Draft Prescription Drug User Fee Act IV Drug Safety Five-Year Plan [Text] [PDF] (Posted May 5, 2008)
  • Draft Prescription Drug User Fee Act (PDUFA) IV Information Technology Plan [Text] [PDF] (Posted 1/4/2008)
  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2008 [Text] [PDF] (Posted 10/15/2007)

  • Prescription Drug User Fee Act; Public Meeting, February 16, 2007 [Text] [PDF] (Posted 1/11/2007)
  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2007. [Text] [PDF] (Posted 8/2/2006)

  • Prescription Drug User Fee Act; Public Meeting [Text] [PDF] (10/18/2005)
  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2006. [Text] [PDF] (Posted 8/1/2005)

  • Notice of Availability: Guidance for Industry and Food and Drug Administration Staff: Application User Fees for Combination Products [Text] [PDF].  The Final Guidance [PDF] (5/3/2005)
     
  • Notice of Availability: Draft Guidance for Industry on User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR [Text] [PDF].  The Draft Guidance [Word]  [PDF] (Posted 4/19/2005)
     
  • Notice of Availability: Guidance for Industry on Good Review Management Principles for PDUFA Products. [Text] [PDF] The Final Guidance [Text] or [Word] or [PDF] (Posted 4/11/2005)
     
  • Notice to Industry on the Development of a Web-Based System for Obtaining a User Fee Payment Identification Number and Prescription Drug User Fee Cover Sheet (FDA Form 3397); Availability.  [Text] [PDF] (3/10/2005)
     
  • Notice of Availability: Guidance for Industry on Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees. [Text] [PDF] The Final Guidance [Text] [PDF] (1/3/2005)
     
  • Notice of Availability: Draft Guidance for Industry and Food and Drug Administration Staff: Application User Fees for Combination Products. [Text] [PDF]  The Draft Guidance pdf.gif (146 bytes) (9/29/2004)
     
  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2005. [Text] [PDF] (Posted 7/30/2004)
     
  • Statement of Work for the Evaluation of First Cycle Review Performance, Availability. [Text] [PDF] (Posted 10/21/2003).
     
    • Sample Statement of Work for the Evaluation of First Cycle Review Performance. [Word] [PDF] (10/21/2003)

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2004.  [Text] [PDF] (Posted 8/1/2003)

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2003.  [Text] [PDF] (Posted 8/2/2002)

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2002. [Text] [PDF] (Posted 1/14/2002)

  • Prescription Drug User Fee Act (PDUFA); Public Meeting; Correction. [Text] [PDF] (12/4/2001)

  • Prescription Drug User Fee Act (PDUFA); Public Meeting Notice. [Text] [PDF] [FDA PDUFA Meeting Page] (11/21/2001)

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2001.  Pages  79107-79111 [FR Doc. 00-31949]  [Text] [PDF] (12/18/2000)

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 2000 (64 FR 72699, December 28, 1999) [Text]  [PDF]

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 1999 (63 FR 70777, December 22, 1998)  [Text]  [PDF]

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 1998 (62 FR 64849, December, 9, 1997)  [Text] or [PDF]

  • Establishment of Prescription Drug User Fee Rates for Fiscal Year 1998, Correction (62 FR 67878, December 30, 1997) [Text] or [PDF]

  • Delegations of Authority and Organization; Office of the Commissioner and the Center for Drug Evaluation and Research (64 FR 59617, November 3, 1999) [HTML] or [PDF] (11/19/1999)

    Note: This notice transfers the waiver program to CDER. It also has the address where waiver requests can be submitted.

 

 

Back to Top      Back to PDUFA

PDF requires the free Adobe Acrobat Reader

Date created: January 31, 2007, updated August 1, 2008

 

horizonal rule